India's top court to rule on survival of revocation pleas for expired patents
India’s top court will decide whether patent revocation proceedings survive patent expiry, in Boehringer’s Linagliptin dispute with Macleods. The Supreme Court of India's ruling is expected to reshape pharmaceutical litigation, patent...To view the full article, register now.
Already a subscriber? Click here to view full article